Pat Brady
Vice President, Investments
Life Sciences
Prior to joining GrowthWorks Capital in 1998, Pat Brady worked six years at Inex Pharmaceuticals (now Tekmira Pharmaceuticals) and DynaMotive Technologies Corp. in financial and corporate development capacities. Pat currently serves as a Board director or observer for Celator Technologies, Inimex Pharmaceuticals Inc., MSI Methylation Sciences Inc., Valocor Therapeutics and Xenon Genetics. He has also served as a Board member for Neuromed Pharmaceuticals (now Zalicus Inc.), Neurostream Technologies, OncoGenex Technologies, Protiva Biotherapeutics (now Tekmira Pharmaceuticals), and Twinstrand Therapeutics. Pat holds an MBA from the University of Western Ontario and was a former professional athlete. He is a past director of the BC Biotech Association. |
|
 |